Explaining Sedentary Behavior With Planning (the Revised HAPA Model)

March 15, 2024 updated by: Aleksandra Luszczynska, University of Social Sciences and Humanities, Warsaw

Explaining Sedentary Behavior With the Revised Reflective + Impulsive Health Action Process Approach (HAPA) Model

This study would investigate the effects of forming action plans on a reduction of sedentary behaviors. Participants will be randomly assigned to either active control group (education on sedentary behaviors and physical activity) or the intervention group (forming action plans referring to replacing sedentary activities with physical activity. The effects of the intervention will be evaluated at the 2-month follow-up and at the 8-month follow-up.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The effects of three sessions (3 education sessions versus 3 education sessions+ forming plans to replace sedentary behavior with physical activity) will be investigated among participants from three age groups: adolescents (12-17 years old), adults (18-60 years old), and older adults (>60 years old). Compared to education only, forming plans about how to replace time spent on sedentary activities with physical activity is expected to result in a significantly larger change (a reduction) of sedentary time at the follow-up. Accelerometers will be used to evaluate short-term and mid-term changes in total sedentary time and the relative proportion of time spent on sedentary behavior vs light-intensity and moderate-to-vigorous- intensity physical activity.

Additionally, the study will observe changes in if the cognitions included in the Health Action Process Approach model (HAPA), such risk perception, self-efficacy, outcome expectancies, intention, action control, as well as changes in behavioral habit, presence of sedentary behavior cues in physical environment, and physical activity behavior. The observations will be conducted three times, at the baseline (before the intervention), the 2-month follow up, and at the 8-month follow-up.

Study Type

Interventional

Enrollment (Estimated)

900

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Lower Silezia
      • Wroclaw, Lower Silezia, Poland, 53-328
        • Recruiting
        • SWPS University of Social Sciences and Humanities
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Zofia Szczuka, MA
        • Sub-Investigator:
          • Ewa Kulis, MA
        • Sub-Investigator:
          • Monika Boberska, MA
        • Sub-Investigator:
          • Magdalena Kruk, MA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • not meeting physical activity guidelines proposed by the World Health Organization

Exclusion Criteria:

  • any existing diseases with contraindications for moderate intensity physical activity, confirmed by patient's primary care physician or a specialist in cardiovascular diseases/endocrinology/rehabilitation medicine providing care for the patient during the recruitment and follow-ups

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Planning + Education

3 education sessions + 1 planning session (integrated into the 3rd education session); delivered face-to-face over 3 weeks (after the baseline measurement), individually.

Planning: The planning materials and forms have sections: (a) instructions of what should be included in a good plan (the when, where, and how components), (b) formulating action and coping plans. Action plans (referring to when, when, and how the individual will act) as well as coping plans (referring to how to overcome potential difficulties) will be formed. After forming the plans individually, experimenters will discuss the plans with the participants.

Planning: Participants will fill in the planning forms that efer to replacing sedentary behavior with physical activity.

The following behavior change techniques are included in the planning intervention protocol: action planning, barrier identification, prompting self-talk, relapse prevention/coping planning. Applications of all behavior change techniques would include references to planning.

The education would include extended sedentary behavior and physical activity education, delivered face-to-face by the experimenters. The education includes: (1) the behavioral guidelines, tailored to age and health status of the participants, (2) the examples of exercises and their metabolic equivalent, and (3) the education about ways to break sedentary behavior with active breaks.
Active Comparator: Education

3 education sessions; delivered face-to-face over 3 weeks (after the baseline measurement), individually.

The education includes extended physical activity and sedentary behavior education using participant-educator discussions and printed materials.

The education would include extended sedentary behavior and physical activity education, delivered face-to-face by the experimenters. The education includes: (1) the behavioral guidelines, tailored to age and health status of the participants, (2) the examples of exercises and their metabolic equivalent, and (3) the education about ways to break sedentary behavior with active breaks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sedentary behavior
Time Frame: change from the baseline sedentary behavior at 8 months
minutes of sedentary behavior per day assessed with ActiGraph wGT3X-BT accelerometer
change from the baseline sedentary behavior at 8 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The composition of waking time
Time Frame: change from the baseline composition of waking time at 8 months
the proportion of time spent on sedentary behavior (minutes per day) to time spent on light-intensity physical activity (minutes per day) and moderate-to-vigorous physical activity (minutes per day) assessed with ActiGraph wGT3X-BT accelerometer
change from the baseline composition of waking time at 8 months
Physical activity
Time Frame: change from the baseline physical activity at 8 months
minutes of light, moderate and vigorous intensity physical activity per day measured with ActiGraph wGT3X-BT accelerometer
change from the baseline physical activity at 8 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sedentary behavior habit
Time Frame: change from the baseline sedentary behavior habit at 8 months
Self-Reported Habit Scale; mean item score ranging from 1 to 4, higher scores indicate stronger sedentary behavior habit
change from the baseline sedentary behavior habit at 8 months
Self-efficacy for reducing sedentary behavior
Time Frame: change from the baseline self-efficacy at 8 months
9 self-efficacy questionnaire items; mean item score ranging from 1 to 4, higher scores indicate stronger self-efficacy
change from the baseline self-efficacy at 8 months
Risk perception
Time Frame: change from the baseline risk perception at 8 months
3 questionnaire items to assess risk perception; mean item score ranging from 1 to 4, higher scores indicate higher risk perception
change from the baseline risk perception at 8 months
Outcome expectancies
Time Frame: change from the baseline outcome expectancies at 8 months
18 items assessing positive (9 items) and negative (9 items) outcome expectancies; item score ranging from 1 to 4, higher scores indicate more positive outcome expectancies
change from the baseline outcome expectancies at 8 months
Action control
Time Frame: change from the baseline outcome expectancies at 8 months
10 questionnaire items assessing action control; mean item score ranging from 1 to 4, higher scores indicate stronger action control
change from the baseline outcome expectancies at 8 months
Intention
Time Frame: change from the baseline intention at 8 months
3 questionnaire items assessing intention to reduce sedentary behavior; mean item score ranging from 1 to 4, higher scores indicate stronger intention to reduce sedentary behavior
change from the baseline intention at 8 months
Self-reported planning
Time Frame: change from the baseline planning at 8 months
4 questionnaire items assessing action planning; mean item score ranging from 1 to 4, higher scores indicate a higher level of self-reported planning
change from the baseline planning at 8 months
Environmental cues for sedentary behavior
Time Frame: change from the baseline planning at 8 months
10 questionnaire items assessing physical environment cues for sedentary behavior and its reduction; the total sum score ranging from 0 to 10; higher scores indicate more environmental cues for sedentary behavior
change from the baseline planning at 8 months
Body mass index (BMI)
Time Frame: change from the baseline planning at 8 months
Certified and standardized body weight scales (Beurer; European Union safety certificate; measurement error < 5%) and measuring rods will be used. Body mass index will be calculated using the following formula: body weight [in kg] divided by a square of body height (in meters). Body weight will be recorded in kilograms and body height will be recorded in meters.
change from the baseline planning at 8 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Aleksandra Luszczynska, PhD, SWPS University of Social Sciences and Humanities

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 2, 2020

Primary Completion (Estimated)

March 30, 2024

Study Completion (Estimated)

March 30, 2024

Study Registration Dates

First Submitted

October 15, 2019

First Submitted That Met QC Criteria

October 17, 2019

First Posted (Actual)

October 18, 2019

Study Record Updates

Last Update Posted (Actual)

March 18, 2024

Last Update Submitted That Met QC Criteria

March 15, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • USSHWarsaw
  • 2017/27/B/HS6/00092 (Other Grant/Funding Number: National Science Centre, Poland)
  • 2021/43/O/HS6/00712/ (Other Grant/Funding Number: National Science Centre, Poland)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified individual participant data for all primary, secondary, and additional outcome measures will be made available.

IPD Sharing Time Frame

Respective data will be made available together with the submission of the manuscript reporting the findings for the main outcome (not later that within 2 years after the completion of data collection).

IPD Sharing Access Criteria

Data will be uploaded on Open Science Framework, available to researchers who will have a respective link.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sedentary Behavior

Clinical Trials on Planning + Education

3
Subscribe